Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,995,063 papers from all fields of science
Search
Sign In
Create Free Account
10 ML nivolumab 10 MG/ML Injection [Opdivo]
Known as:
NIVOLUMAB 10 mg in 1 mL INTRAVENOUS INJECTION [OPDIVO]
, Opdivo 100 MG in 10 ML Injection
, Opdivo 100 MG per 10 ML Injection
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Hydrochloric Acid
Injection
Mannitol
Pentetic Acid
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Nivolumab vs investigator ’ s choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck : Efficacy and safety in CheckMate 141 by prior cetuximab use
2019
Corpus ID: 157059814
104 Clinical Science Symposium: "Check" This Out: The Step Beyond PD-1 Blockade Sunday, June 4, 10:12–10:24 AM, Hall D1 Clinical…
Expand
2019
2019
Hochrisiko-nmCRPC: Enzalutamid schließt Therapielücke
Dr. Yuri Sankawa
Uro-News
2019
Corpus ID: 59603070
— Die gegenwärtigen Leitlinienempfehlungen zur systemischen Erstlinientherapie bei Patienten mit fortgeschrittenem und/ oder…
Expand
2018
2018
Nivolumab (Opdivo®) in combination with ipilimumab (Yervoy®) for the first-line treatment of patients with advanced RCC
E. Rothschedl
2018
Corpus ID: 81053359
Renal cell carcinomas (RCCs) arise from the renal cortex; many patients with RCC are asymptomatic until the disease is either…
Expand
2018
2018
Immuntherapie bei metastasiertem Nierenzellkarzinom
D. T. Meißner
Uro-News
2018
Corpus ID: 59602977
— Die gegenwärtigen Leitlinienempfehlungen zur systemischen Erstlinientherapie bei Patienten mit fortgeschrittenem und/ oder…
Expand
2017
2017
First Patient Dosed in a Phase 1 / 2 Trial of Pexa-Vec + Opdivo ® for the First-Line Treatment of Advanced Liver Cancer
2017
Corpus ID: 166220677
Strasbourg, France, July 31, 2017, 5:45 p.m. CET Transgene (Euronext Paris: TNG), a company that designs and develops viral-based…
Expand
2017
2017
Nivolumab (Opdivo°) and metastatic or inoperable lung cancer.
Prescrire international
2017
Corpus ID: 73417016
2017
2017
Câncer renal ganha novo tratamento
Núcleo Ipê
2017
Corpus ID: 57811129
Pacientes com câncer renal ganharam uma nova opcao de tratamento com a aprovacao de nova indicacao terapeutica para o produto…
Expand
2016
2016
UC Davis to Conduct Phase 2 Trial of the Combination of TG 4010 with Opdivo ® ( nivolumab ) for 2 nd Line Treatment of Metastatic Non-Small Cell Lung Cancer ( NSCLC )
K. Kelly
2016
Corpus ID: 162178821
Strasbourg, France, December 7, 2016, 5:45 pm CET — Transgene (Euronext Paris: TNG), a company focused on designing and…
Expand
2016
2016
Nivoluman (Opdivo®): melanoma avanzado y cáncer de pulmón no microcítico
S. Cuéllar
2016
Corpus ID: 77634959
2015
2015
Nivolumab (Opdivo®) as single-agent first-line therapy for unresectable or metastatic melanoma
M. Ujeyl
,
A. Nachtnebel
2015
Corpus ID: 68934397
Nivolumab is a fully human IgG4 monoclonal antibody that blocks the binding of the programmed cell death receptor-1 protein (PD-1…
Expand